Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Near-perfect genome sequencing in medical genetics.

Nature genetics·2026
Same author

Clinical Long-Read Genome Sequencing for Rare-Disease Diagnostics.

The New England journal of medicine·2026
Same author

HiFi sequencing accurately identifies clinically relevant variants in paralogous genes.

American journal of human genetics·2026
Same author

Monoallelic PSMB8 variants cause PRAAS with immunodeficiency through impaired immunoproteasome assembly.

American journal of human genetics·2026
Same author

Transcription-based identification of uncharacterized genes in the human immune response.

European journal of human genetics : EJHG·2026
Same author

A 5' UTR CCG expansion in <i>TBC1D7</i> causes oculopharyngodistal myopathy.

medRxiv : the preprint server for health sciences·2026

Related Experiment Video

Updated: May 24, 2026

Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in a Feline Large Animal Model
07:43

Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in a Feline Large Animal Model

Published on: August 5, 2021

Next-generation genetic testing for retinitis pigmentosa.

Kornelia Neveling1, Rob W J Collin, Christian Gilissen

  • 1Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.

Human Mutation
|February 16, 2012
PubMed
Summary

Next-generation sequencing (NGS) offers a powerful tool for diagnosing retinitis pigmentosa (RP), a genetically diverse condition. This study successfully identified causative mutations in 36% of previously undiagnosed RP patients using a comprehensive NGS approach.

More Related Videos

Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System
07:04

Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System

Published on: February 4, 2021

Related Experiment Videos

Last Updated: May 24, 2026

Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in a Feline Large Animal Model
07:43

Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in a Feline Large Animal Model

Published on: August 5, 2021

Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System
07:04

Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System

Published on: February 4, 2021

Area of Science:

  • Ophthalmology
  • Genetics
  • Molecular Biology

Background:

  • Retinitis pigmentosa (RP) presents significant diagnostic challenges due to extreme genetic and clinical heterogeneity, with 52 known causative genes.
  • Existing molecular diagnostic methods struggle to keep pace with the complexity of inherited retinal diseases.

Purpose of the Study:

  • To develop and validate a comprehensive next-generation sequencing (NGS) approach for the clinical molecular diagnosis of RP.
  • To improve the diagnostic yield in patients with genetically heterogeneous inherited retinal diseases.

Main Methods:

  • A custom NGS panel capturing 111 known inherited retinal disease genes was designed.
  • 100 RP patients lacking a molecular diagnosis underwent simultaneous gene capture and NGS analysis.
  • A systematic data analysis pipeline was developed to prioritize and predict variant pathogenicity, followed by segregation analysis and in silico predictions.

Main Results:

  • The NGS approach successfully reduced the number of potential pathogenic variants per patient from ~1,200 to 0-9.
  • A molecular diagnosis was achieved in 36 out of 100 (36%) RP patients.
  • Diagnoses included 27 recessive, six dominant, and three X-linked forms of RP.

Conclusions:

  • NGS is highly effective for the molecular diagnosis of genetically complex diseases like RP, demonstrating significant clinical utility.
  • De novo dominant mutations are a notable cause of isolated RP cases, impacting genetic counseling strategies.
  • This comprehensive NGS strategy significantly enhances diagnostic capabilities for inherited retinal diseases.